As we approach our 13th anniversary on June 16, we pause to celebrate important milestones and extend our deepest gratitude to our staff, partners and clients who have been part of our growth journey! From our humble beginnings to becoming a global full-service CRO focused on vaccines and infectious diseases, each step has been marked by dedication and a commitment to excellence. 

Joining forces with Ampersand Capital Partners in May 2023 and our merger with OnQ Research in October 2023, were pivotal moments allowing us to expand our capabilities and physical presence in over 30 countries. The opening of our new office in North Carolina, USA, in early 2024, further exemplified our commitment to becoming a global force in the healthcare sector. We look forward to continuing our mission of delivering innovative solutions and making a positive impact on global health. 

Happy birthday P95!

More about P95’s history